The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Hematologic disorders and ischemic stroke. A selective review.
Open accessAbstract
More than a dozen primary hematologic disorders have been associated with ischemic stroke. Inherited deficiencies of antithrombin III, protein C, and protein S have been linked with stroke in case reports; optimal screening requires functional as well as antigenic assays. Antiphospholipid antibodies and lupus anticoagulants are the most frequently identified acquired states associated with ischemic stroke. Polycythemia vera, sickle cell anemia, sickle-C disease, and essential thrombocythemia are the major disorders of formed blood elements causing stroke. Special, step-wise screening for occult prothrombotic entities in stroke patients is recommended for young persons with stroke of uncertain cause, for those with prior venous thrombosis, for those with a family history of unusual thrombosis, and for those with no other explanation for recurrent stroke. Acquired, perhaps transient, abnormalities of platelets, coagulation inhibition, and fibrinolysis may contribute importantly to brain ischemia in synergy with other mechanisms, but at present these remain ill-defined. The contribution of prothrombotic diatheses to stroke is probably underrecognized and warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of stroke in sickle cell disease
Powars, D., Wilson, B., Imbus, C., Pegelow, C., & Allen, J. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90772-6 · Cited by 594 · cited 1×
“-(132)-(134)-(135) The mean age for ischemic stroke in such patients is approximately 10 years; in young adults hemorrhagic strokes are more frequent.(135)-(137) The pathophysiology of cerebral ischemia is a complex and chronic process, with intimal hyperplasia and thrombosis, occasionally resulting in moyamoya-like a…”
BackgroundSickle cell anemia and central nervous system infarction: A neuropathological study
Rothman, S. M., Fulling, K. H., & Nelson, J. S. (1986) · Annals of Neurology · doi:10.1002/ana.410200606 · Cited by 228
Merkel, K. H., Ginsberg, P. L., Parker, J. C., & Post, M. J. (1978) · Stroke · doi:10.1161/01.str.9.1.45 · Cited by 216
The sensitivity of different coagulation reagents to the presence of lupus anticoagulants
(1986) · Thrombosis Research · doi:10.1016/0049-3848(86)91499-4 · Cited by 74
Cited by
Amir, E., Seruga, B., Niraula, S., Carlsson, L., & Ocaña, A. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr242 · Cited by 622
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Antithrombotic Therapy in Children
Michelson, A. D., Bovill, E., Monagle, P., & Andrew, M. (1998) · Chest · doi:10.1378/chest.114.5_supplement.748s · Cited by 425
Antithrombotic Therapy in Children*
Monagle, P., Chan, A., Massicotte, P., Chalmers, E., & Michelson, A. D. (2004) · Chest · doi:10.1378/chest.126.3_suppl.645s · Cited by 395
Prospective study of endogenous tissue plasminogen activator and risk of stroke
Ridker, P. M., Hennekens, C. H., Manson, J. E., Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Vaughan, D. E., Hennekens, C. H., & Stampfer, M. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90064-7 · Cited by 305
Metadata
- Authors
- Hart, R. G., & Kanter, M. C.
- Venue
- Stroke
- Published
- 1990-08
- Volume
- 21
- Issue
- 8
- Pages
- 1111-1121
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2122313563
- Cited by
- 230
- References
- 4
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.